Epistaxis Market

Epistaxis Market Analysis By Product (Vasoconstrictors, Anesthetics, Antibiotic Ointments), By Indication (Posterior, Anterior Epistaxis), By Distribution Channel (Hospitals, Specialty Clinics, Retail Pharmacies), By Region - Global Insights 2022-2032

Analysis of Epistaxis Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Global Epistaxis Market Outlook (2022 to 2032)

The global epistaxis market is evaluated at USD 193.5 Million in 2022 and is forecast to outshine USD 332.0 Million by 2032, mounting at a CAGR of 5.5% from 2022 to 2032.

Global epistaxis market is holding nearly 1% market share in global ear nose and throat (ENT) treatment market which is likely to grow at a CAGR of 6% during the forecast years.

Report Attributes


Base Year Value (2021A)

USD 184.7 Million

Estimated Year Value (2022E)

USD 193.5 Million

Projected Year Value (2032F)

USD 332.0 Million

Global Growth Rate (2022-2032)


North America Market Share in 2021


North America Growth Rate (2022-2032)


Collective Value Share (China, USA, Germany) 2022: Top 3 Countries


Top 5 Companies Market Share in 2021


Key Companies Profiled

  • Bristol-Myers Squibb Company
  • Ciron Drugs & Pharmaceuticals Pvt. Ltd.
  • Pfizer Inc.
  • Medline Industries Inc.
  • Smith & Nephew
  • GlaxoSmithKline PLC
  • Ferring B.V.
  • Other Key Players

Don't Need a Global Report?

save 40%! on Country & Region specific reports

2017-2021 Global Epistaxis Market Outlook in Comparison to 2022-2032 Growth Forecast

All along 2017-2021, the historic year's global epistaxis market experienced slow-moving growth of 3.5% CAGR. Customers with the increasing needs and increased expenditure by the governments in the advancement of technologies have boomed the epistaxis market during the covid-19 pandemic.

The demand of epistaxis can be assessed throughout the long-term forecast period by bifurcating the forecast timeline into three sections.

  • Short-term: retrieval growth is projected during the upcoming Triennials.
  • Medium-term: the demand normalization is projected to grow during mid-term.
  • Long-term: epistaxis product demand and pricing are affected by inflation rates, technologies and economic cycles.

The demand of epistaxis is likely to grow at a constant rate during the valuation period with a CAGR of 5.5%. Creating a constructive circumstances for market players, with the focus on the inclusion of health safety features in the epistaxis.

Fact.MR projects the epistaxis market is likely to observe the growth of 5.5% CAGR over 2022 & 2032 in comparison to a CAGR of 3.5% with which it grew from 2017 and 2021.

Harsh Environmental Conditions and Extreme Temperatures Trigger Nasal Bleeding

Extreme weathers during different seasons like, dry and cold weather during winters or intensively hot temperatures during summer can cause epistaxis or nasal bleeding among children as well as adults. Excessive heat and dryness in the air can dry out the nasal membranes, and it removes the quantity of moisture essential to be maintained in the nose normally.

In addition, epistaxis is one of the most common health problems observed among children, adults, and the elderly to be occurred in severe summers or extremely cold winters, as the less humid weather dries out the nasal membrane causing it to bleed abnormally. An increase in such nosebleed occurrences during extreme dry, hot, cold, or less humid weather across the globe is generating needs for various epistaxis treatment products to treat abnormal nosebleed problems.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Increasing Number of Patients in the World Who are Suffering from Hypertension

Individuals who are suffering from hypertension are the most susceptible to epistaxis, as hypertension and epistaxis are two health conditions that are interrelated to each other. Nosebleed is one of the primary symptoms of hypertension as nasal bleeding occurs when the blood pressure levels are high, and hence hypertension becomes one of the primary causes of epistaxis.

As epistaxis is associated with blood disorders, hypertension becomes one of the systematic factors that trigger spontaneous bleeding in the mucous membrane in the nose. According to the facts declared by the World Health Organization (WHO), more than 12% of the deaths caused in the world were caused due to hypertension, which makes hypertension one of the leading causes of death.

Also the age of males as well as females who are susceptible to hypertension has lowered across the globe, and number of young individuals suffering from hypertension has increased over the past few years. Nosebleed hypertension is a direct cause of epistaxis, and its occurrence in individuals increases with the increasing number of patients with hypertension in the world.

Incidences of Adverse Effects from Different Epistaxis Treatments Such as Nasal Cauterization

Although various advancements in epistaxis treatments are resulting in greater success rates in curing epistaxis completely, there are some side effects of these treatments which can worsen the problem of epistaxis in the patient.

Further, various epistaxis treatment procedures such as nasal cauterization, nasal packing, etc., have rare but existing side effects, which hinder the growth of the global epistaxis market as patients might choose to go for equivalent alternatives to these epistaxis treatment procedures. Some patients might get allergic reactions to antibiotic ointments that are supposed to stop nasal bleeding by moisturizing the membrane.

If the epistaxis treatment procedures happen to fail at any level, the nasal bleeding can recur eliminating the complete effect of the procedure. In treatments like nasal packing, excessive bleeding can be caused in different areas of the body of the patient due to traumatic insertion of nasal packs. Side effects of nasal cauterization can be caused due to an overdose of acid used for closing the blood vessels, which can create a hole in the nose.

Moreover, anesthetics used in epistaxis treatments carry the risk of causing complications in the treatment resulting in damaging the health of the patient and death in rare cases. Such side effects of epistaxis products and treatment procedures are restricting the growth of the global epistaxis market.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Country-wise Insights

Why the United States has Enormous Market for Epistaxis?

The developed healthcare sector in the North American region and increased consumer awareness about various procedures to treat nasal bleeding problems like epistaxis are among the primary drivers of the North American epistaxis market, which contribute to making it the most lucrative region in the global epistaxis market.

Further, advanced research conducted in the medical field and inventions of new drugs and treatments to treat various health-related issues effectively lead to the growing demands for innovative products for epistaxis treatment in the United States.

Moreover, the lifestyles changes of the consumers in the US, like smoking trends, air pollution etc., create an auspicious atmosphere for consumers to be susceptible to the primary causes of epistaxis.

Further, with the increasing demand for epistaxis treatment products, owing to the increasing occurrence of health problems like a common cold, and strict regulatory laws for developing and distributing a new drug in the markets, the North American epistaxis market is likely to maintain a sound growth throughout the forecast period.

Why is Chinese Epistaxis market making huge market for epistaxis?

Amongst the six geographical regions in the global epistaxis market, the East Asian epistaxis market is projected to witness rapid growth to be the most lucrative market for the pharmaceutical industries in the world.

With the developing economies enticing foreign investments in the pharmaceutical industry and China being among the prominent pharmaceutical industry in the world, the East Asian epistaxis market is likely to accomplish significant growth over the assessment period.

China's epistaxis market is estimated to cross the valuation of USD 61 million during 2022 & 2032. The demand for epistaxis are expected to grow by 1.6X times throughout the forecast period.

Epistaxis market forecast by Fact.MR

Category-wise Insights

Which product type has highest in demand in the Epistaxis Market?

The types of products that are popularly used in the treatment procedures for epistaxis include vasoconstrictors, anaesthetics, antibiotic ointments, and cauterizing agents. Due to their effectiveness in treating epistaxis, cauterizing agents are the most popularly used products in epistaxis treatment procedures, across the globe.

Epistaxis’ foremost symptom is bleeding which confirms the epistaxis’ presence. However, cauterizing agents coagulate cellular proteins, which can, in turn, decrease the bleeding and help in handling the over bleeding. Owing to this, it is widely used by medical professionals.

However, cauterizing agents segment is the largest product type in the global market, which is holding more than 2/5th of market shares of the global epistaxis market. It’s projected to offer an absolute dollar opportunity of nearly USD 58 million with a growth of 4.2% CAGR.

Which Distribution Channel is Poised to Show Lucrative Growth in Epistaxis Market?

The leading companies have robust distribution channels where companies have partnered with hospitals, specialty clinics, retail pharmacies and others. However, the majority of consumers choose to take treatments from hospitals and retail pharmacies owing to convenience and trust issues.

However, the hospitals distribution channel is the largest distribution channel in the global epistaxis market. It is contributing with nearly 2/5th shares of the market. Hospitals segment is expected to grow at 3.1% CAGR.

Competitive Landscape: Top Companies in Epistaxis Market

To recover diffusion across profitable markets, the aforementioned players use various organic and inorganic strategies. Product launches, alliances and agreements with key epistaxis suppliers, acquisitions, and geographical expansion are all part of these strategies.

Fact.MR has provided detailed information about price points of top providers in epistaxis market positioned across regions, sales growth, production capacity, and speculative technological expansion in the recently published report.

For instance :

  • In August 2021, the company Pfizer Inc. has signed an agreement to acquire Trillium Therapeutics Inc., this acquisition will help company to strengthen the company’s presence in global market
  • In January 2022, Ascend Wellness Holdings has signed a partnership agreement with Siemens Healthineers, to expand the its testing capacity in the Ascend’s new laboratory in California

Global Epistaxis Market by Category

  • By Product, Global Epistaxis Market is segmented as:

    • Vasoconstrictors
    • Anesthetics
    • Antibiotic Ointments
    • Cauterizing Agents
  • By Distribution Channel, Global Epistaxis Market is segmented as:

    • Hospitals
    • Specialty Clinics
    • Retail Pharmacies
    • Other Distribution Channels
  • By Indication, Global Epistaxis Market is segmented as:

    • Posterior Epistaxis
    • Anterior Epistaxis
  • By Region, Global Epistaxis Market is segmented as:

    • North America
    • Latin America
    • Europe
    • East Asia
    • South Asia & Oceania
    • MEA

- FAQs -

What is the global Epistaxis Market scenario?

The global value of epistaxis market is estimated to be worth over USD 193.5 Million in 2022.

How far is the global demand expected to reach over the forecasted period?

The demand is anticipated to surpass USD 332.0 Million by 2032 end.

What was the last 5-year CAGR for the demand in the Epistaxis Market?

During 2017-2021, global epistaxis market grew at 3.5% CAGR.

Who are the prominent players in the global Epistaxis Market?

Some of the prominent players in epistaxis market are Bristol-Myers Squibb Company, Ciron Drugs & Pharmaceuticals Pvt. Ltd., Pfizer Inc., Medline Industries Inc. etc.

Which is the most leading region in the Epistaxis Market?

North America tops the global epistaxis market accounting for more than 1/3rd of global market share in 2022.

Which distribution channel contributes maximum share in Epistaxis Consumption?

Hospitals segment contributes by nearly 2/5th of market share in global consumption of epistaxis.

Epistaxis Market

Schedule a Call